Background: The primary treatment of ulcerative colitis (UC) is conservative; surgical intervention is carried out in the case of therapy-refractory situation, imminent or malignant transformation, or complications. Surgery for UC should be indicated by interdisciplinary means. Despite the development of drug therapy - in particular the introduction of biologics -, a surgical intervention becomes necessary in a relevant proportion of patients with UC throughout lifetime. Methods: A selective literature search was conducted, taking into account the current studies, reviews, meta-analyses, and guidelines. PubMed served as a database. The present work gives an overview of the surgical options, outcome as well as peri- and postoperative management for patients with UC. Results: Approximately 20% of patients with UC will require surgery during the course of their disease. The rate of colectomy after a disease duration of 10 years is at approximately 16%. Unlike Crohn's disease, UC is principally surgically curable since it is naturally limited to the colon and rectum. Restorative proctocolectomy with an ileal pouch-anal anastomosis represents the surgical treatment of choice. Large studies show a postoperative complication rate of around 30% and a low mortality of 0.1% for this procedure. Chronic pouchitis is one of the main factors limiting the surgical success of curing UC. Despite a high postoperative complication rate, there is a long-term pouch success rate of >90% after 10 and 20 years of follow-up. Conclusion: A close cooperation between the various disciplines in the pre- and postoperative setting is essential for an optimal outcome of patients with UC. Despite a 30% rate of early postoperative complications, normal quality of life can ultimately be reached in more than 90% of patients in experienced centers.

Journal Section:
Editor's choice
Keywords:
Ulcerative colitis, Surgery, IPAA, Pouchitis
1.
Molodecky NA, Soon IS, Rabi DM, et al: Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012;142:46-54.
2.
Frolkis AD, Dykeman J, Negrón ME, et al: Risk of surgery for inflammatory bowel diseases has decreased over time: a systematic review and meta-analysis of population-based studies. Gastroenterology 2013;145:996-1006.
3.
Dignass A, Preiss JC, Aust DE, et al: Updated German guideline on diagnosis and treatment of ulcerative colitis, 2011 (Article in German). Z Gastroenterol 2011;49:1276-1341.
4.
Gan SI, Beck PL: A new look at toxic megacolon: an update and review of incidence, etiology, pathogenesis, and management. Am J Gastroenterol 2003;98:2363-2371.
5.
Eaden JA, Abrams KR, Mayberry JF: The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001;48:526-535.
6.
Devaraj B, Kaiser AM: Surgical management of ulcerative colitis in the era of biologicals. Inflamm Bowel Dis 2015;21:208-220.
7.
Singh P, Bhangu A, Nicholls RJ, et al: A systematic review and meta-analysis of laparoscopic vs open restorative proctocolectomy. Colorectal Dis 2013;15:e340-351.
8.
Fazio VW, Kiran RP, Remzi FH, et al: Ileal pouch anal anastomosis: analysis of outcome and quality of life in 3707 patients. Ann Surg 2013;257:679-685.
9.
Kaplan GG, McCarthy EP, Ayanian JZ, et al: Impact of hospital volume on postoperative morbidity and mortality following a colectomy for ulcerative colitis. Gastroenterology 2008;134:680-687.
10.
Stocchi L, Pemberton JH: Pouch and pouchitis. Gastroenterol Clin North Am 2001;30:223-241.
11.
Batista D, Raffals L: Role of intestinal bacteria in the pathogenesis of pouchitis. Inflamm Bowel Dis 2014;20:1481-1486.
12.
Landy J, Al-Hassi HO, McLaughlin SD, et al: Etiology of pouchitis. Inflamm Bowel Dis 2012;18:1146-1155.
13.
Gionchetti P, Rizzello F, Venturi A, et al: Antibiotic combination therapy in patients with chronic, treatment-resistant pouchitis. Aliment Pharmacol Ther 1999;13:713-718.
14.
Holubar SD, Cima RR, Sandborn WJ, et al: Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis. Cochrane Database Syst Rev 2010;6:CD001176.
15.
Ikeuchi H, Uchino M, Matsuoka H, et al: Surgery for ulcerative colitis in 1,000 patients. Int J Colorectal Dis 2010;25:959-965.
16.
Heuschen UA, Schmidt J, Allemeyer E, et al: The ileo-anal pouch procedure: complications, quality of life, and long-term results (Article in German). Zentralbl Chir 2001;126:36-42.
17.
Johnson P, Richard C, Ravid A, et al: Female infertility after ileal pouch-anal anastomosis for ulcerative colitis. Dis Colon Rectum 2004;47:1119-1126.
18.
Rajaratnam SG, Eglinton TW, Hider P, et al: Impact of ileal pouch-anal anastomosis on female fertility: meta-analysis and systematic review. Int J Colorectal Dis 2011;26:1365-1374.
19.
Aytac E, Ashburn J, Dietz DW: Is there still a role for continent ileostomy in the surgical treatment of inflammatory bowel disease? Inflamm Bowel Dis 2014;12:2519-2525.
20.
Subramanian V, Saxena S, Kang JY, et al: Preoperative steroid use and risk of postoperative complications in patients with inflammatory bowel disease undergoing abdominal surgery. Am J Gastroenterol 2008;103:2373-2381.
21.
Myrelid P, Olaison G, Sjödahl R, et al: Thiopurine therapy is associated with postoperative intra-abdominal septic complications in abdominal surgery for Crohn's disease. Dis Colon Rectum 2009;52:1387-1394.
22.
Narula N, Charleston D, Marshall JK: Meta-analysis: peri-operative anti-TNFα treatment and post-operative complications in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2013;37:1057-1064.
23.
Michelassi F, Lee J, Rubin M, et al: Long-term functional results after ileal pouch anal restorative proctocolectomy for ulcerative colitis: a prospective observational study. Ann Surg 2003;238:433-441.
24.
McGuire BB, Brannigan AE, O'Connell PE, et al: Ileal pouch-anal anastomosis. Br J Surg 2007;94:812-823.
© 2015 S. Karger GmbH, Freiburg
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2015
You do not currently have access to this content.